US Patent 12110328 Single domain antibodies targeting CD1d

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

January 30, 2023

Date of Patent

October 8, 2024

Patent Application Number

18161163

Patent Citations

‌

US Patent 7728114 Anti-CD3 antibodies and methods of use thereof

‌

US Patent 8012484 Method of treating ischemia reperfusion injury by inhibiting NKT cell activity

‌

US Patent 8084020 Use of anti-CD1 antibodies for the modulation of immune responses

‌

US Patent 8153426 Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

‌

US Patent 8178098 Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies

‌

US Patent 8338173 Preparation of antigen-presenting human γδ T cells and use in immunotherapy

‌

US Patent 10106623 Bispecific antibodies for use in stem cell transplantation

‌

US Patent 10501540 Immunoglobulins binding human Vγ9 Vδ2 T cell receptors

‌

US Patent 10501541 Single domain antibodies targeting CD1d

‌

US Patent 10758625 Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof

•••

Patent Inventor Names

Renée Cornelia Gerarda De Bruin

Roeland Lameris

Hendrik Marinus Willem Verheul

Johannes Jelle Van Der Vliet

Tanja Denise De Gruijl

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12110328

Patent Primary Examiner

‌

Laura B Goddard

Find more entities like US Patent 12110328 Single domain antibodies targeting CD1d

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.